Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries

被引：31

作者：

D'Ascenzo, Fabrizio ^{[1
]}

Biole, Carloalberto ^{[1
]}

Raposeiras-Roubin, Sergio ^{[2
]}

Gaido, Federico ^{[3
]}

Abu-Assi, Emad ^{[2
]}

Kinnaird, Tim ^{[4
]}

Ariza-Sole, Albert ^{[5
]}

Liebetrau, Christoph ^{[6
]}

Manzano-Fernandez, Sergio ^{[7
]}

Boccuzzi, Giacomo ^{[8
]}

Simao Henriques, Jose Paulo ^{[9
,10
]}

Templin, Christian ^{[11
]}

Wilton, Stephen B. ^{[12
]}

Omede, Pierluigi ^{[1
]}

Velicki, Lazar ^{[13
,14
]}

Xanthopoulou, Ioanna ^{[15
]}

Correia, Luis ^{[16
]}

Cerrato, Enrico ^{[17
]}

Rognoni, Andrea ^{[18
]}

Fabrizio, Ugo ^{[8
]}

Nunez-Gil, Ivan ^{[19
]}

Montabone, Andrea ^{[8
]}

Taha, Salma ^{[20
]}

Fujii, Toshiharu ^{[21
]}

Durante, Alessandro ^{[22
]}

Song, Xiantao ^{[23
]}

Gili, Sebastiano ^{[11
]}

Magnani, Giulia ^{[11
]}

Autelli, Michele ^{[1
]}

Bongiovanni, Federica ^{[1
]}

Grosso, Alberto ^{[1
]}

Kawaji, Tetsuma ^{[24
]}

Flores Blanco, Pedro ^{[7
]}

Garay, Alberto ^{[5
]}

Quadri, Giorgio ^{[17
]}

Alexopoulos, Dimitrios ^{[15
]}

Caneiro Queija, Berenice ^{[2
]}

Huczek, Zenon ^{[25
]}

Paz, Rafael Cobas ^{[2
]}

Ramon Gonzalez-Juanatey, Jose ^{[26
]}

Cespon Fernandez, Maria ^{[2
]}

Nie, Shao-Ping ^{[23
]}

Munoz Pousa, Isabel ^{[2
]}

Kawashiri, Masa-aki ^{[27
]}

Rettegno, Sara ^{[1
]}

Gallo, Diego ^{[28
]}

Morbiducci, Umberto ^{[28
]}

Conrotto, Federico ^{[1
]}

Dominguez-Rodriguez, Alberto ^{[9
]}

Valdes, Mariano ^{[7
]}

机构：

[1] Univ Torino, Dept Cardiol, Turin, Italy

[2] Univ Hosp Alvaro Cunqueiro, Dept Cardiol, Vigo, Spain

[3] Univ Torino, Turin, Italy

[4] Univ Hosp Wales, Cardiol Dept, Cardiff, Wales

[5] Univ Hosp Bellvitge, Dept Cardiol, Barcelona, Spain

[6] Kerckhoff Heart & Thorax Ctr, Frankfurt, Germany

[7] Univ Hosp Virgen Arrtixaca, Dept Cardiol, Murcia, Spain

[8] SG Bosco Hosp, Dept Cardiol, Turin, Italy

[9] Univ Hosp Canarias, Dept Cardiol, Tenerife, Spain

[10] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands

[11] Univ Spital, Div Cardiol, Zurich, Switzerland

[12] Cardiovasc Inst Alberta, Calgary, AB, Canada

[13] Univ Novi Sad, Med Fac, Novi Sad, Serbia

[14] Inst Cardiovasc Dis Vojvodina, Sremska Kamenica, Serbia

[15] Univ Patras Hosp, Athens, Greece

[16] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil

[17] San Luigi Gonzaga Univ Hosp, Orbassano & Infermi Hosp, Intervent Unit, Turin, Italy

[18] Maggiore Carita Hosp, Catheterizat Lab, Novara, Italy

[19] San Carlos Hosp, Madrid, Spain

[20] Assiut Univ, Fac Med, Dept Cardiol, Assiut, Egypt

[21] Tokai Univ, Sch Med, Tokyo, Japan

[22] Osped Valduce, UO Cardiol, Como, Italy

[23] Anzhen Hosp, Beijing, Peoples R China

[24] Univ Grad Sch Med, Kyoto, Japan

[25] Univ Clin Hosp, Warsaw, Poland

[26] Univ Clin Hosp, Santiago De Compostela, Spain

[27] Kanazawa Univ, Div Cardiovasc Med, Grad Sch Med, Kanazawa, Ishikawa, Japan

[28] Politecn Torino, PolitoBIOMed Lab, Dept Mech & Aerosp Engn, Turin, Italy

[29] Sapienza Univ Rome, Dept Med Surg Sci & Biotechnol, Latina, Italy

[30] IRCCS Neuromed, Dept AngioCardioNeurol, Pozzilli, Italy

[31] Cardiovasc Res Fdn, Clin Trials Ctr, New York, NY USA

[32] Columbia Univ, New York Presbyterian Hosp, Med Ctr, New York, NY USA

来源：

AMERICAN HEART JOURNAL | 2020年 / 220卷

关键词：

ACUTE CORONARY SYNDROMES; CLOPIDOGREL; PRASUGREL; OUTCOMES; DISEASE; COMPLICATIONS; TICAGRELOR; MANAGEMENT; STENTS;

D O I：

10.1016/j.ahj.2019.10.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background The risk of recurrent ischemia and bleeding after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) may vary during the first year of follow-up according to clinical presentation, and medical and interventional strategies. Methods BIeeMACS and RENAMI are 2 multicenter registries enrolling patients with ACS treated with PCI and clopidogrel, prasugrel, or ticagrelor. The average daily ischemic and bleeding risks (ADIR and ADBR) in the first year after PCI were the primary end points. The difference between ADBR and ADIR was calculated to estimate the potential excess of bleeding/ischemic events in a given period or specific subgroup. Results A total of 19,826 patients were included. Overall, in the first year after PCI, the ADBR was 0.008085%, whereas ADIR was 0.008017% (P = .886). In the first 2 weeks ADIR was higher than ADBR = .013), especially in patients with ST-segment elevation myocardial infarction or incomplete revascularization. ADIR continued to be, albeit non-significantly, greater than ADBR up to the third month, whereas ADBR became higher, although not significantly, afterward. Patients with incomplete revascularization had an excess in ischemic risk (P = .003), whereas non-ST-segment elevation ACS patients and those on ticagrelor had an excess of bleeding (P = .012 and P = .022, respectively). Conclusions In unselected ACS patients, ADIR and ADBR occurred at similar rates within 1 year after PCI. ADIR was greater than ADBR in the first 2 weeks, especially in ST-segment elevation myocardial infarction patients and those with incomplete revascularization. In the first year, ADIR was higher than ADBR in patients with incomplete revascularization, whereas ADBR was higher in non-ST-segment elevation ACS patients and in those discharged on ticagrelor.

引用

页码：108 / 115

页数：8

共 25 条

[1]

[Anonymous], STAND BLEED DEF CARD

[2]

Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]

[3] Angiographic Stent Thrombosis at Coronary Bifurcations Short- and Long-Term Prognosis [J].

Armstrong, Ehrin J. ;

Yeo, Khung Keong ;

Javed, Usman ;

Mahmud, Ehtisham ;

Patel, Mitul ;

Shunk, Kendrick A. ;

MacGregor, John S. ;

Low, Reginald I. ;

Rogers, Jason H. .

JACC-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (01) :57-63

[4] Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial [J].

Becker, Richard C. ;

Bassand, Jean Pierre ;

Budaj, Andrzej ;

Wojdyla, Daniel M. ;

James, Stefan K. ;

Cornel, Jan H. ;

French, John ;

Held, Claes ;

Horrow, Jay ;

Husted, Steen ;

Lopez-Sendon, Jose ;

Lassila, Riitta ;

Mahaffey, Kenneth W. ;

Storey, Robert F. ;

Harrington, Robert A. ;

Wallentin, Lars .

EUROPEAN HEART JOURNAL, 2011, 32 (23) :2933-2944

[5] Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease [J].

Bravo, Claudio A. ;

Hirji, Sameer A. ;

Bhatt, Deepak L. ;

Kataria, Rachna ;

Faxon, David P. ;

Ohman, E. Magnus ;

Anderson, Kevin L. ;

Sidi, Akil I. ;

Sketch, Michael H., Jr. ;

Zarich, Stuart W. ;

Osho, Asishana A. ;

Gluud, Christian ;

Kelbaek, Henning ;

Engstrom, Thomas ;

Hofsten, Dan Eik ;

Brennan, James M. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (05)

[6] Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: A Pathologic study [J].

Cheruvu, Pavan K. ;

Finn, Aloke V. ;

Gardner, Craig ;

Caplan, Jay ;

Goldstein, James ;

Stone, Gregg W. ;

Virmani, Renu ;

Muller, James E. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (10) :940-949

[7] Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study [J].

Cuisset, Thomas ;

Deharo, Pierre ;

Quilici, Jacques ;

Johnson, Thomas W. ;

Deffarges, Stephanie ;

Bassez, Clemence ;

Bonnet, Guillaume ;

Fourcade, Laurent ;

Mouret, Jean Philippe ;

Lambert, Marc ;

Verdier, Valentine ;

Morange, Pierre Emmanuel ;

Alessi, Marie Christine ;

Bonnet, Jean Louis .

EUROPEAN HEART JOURNAL, 2017, 38 (41) :3070-3078

[8] Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients [J].

D'Ascenzo, Fabrizio ;

Iannaccone, Mario ;

Saint-Hilary, Gaelle ;

Bertaina, Maurizio ;

Pke, Stefanie Schulz-Schu ;

Lee, Cheol Wahn ;

Chieffo, Alaide ;

Helft, Gerard ;

Gili, Sebastiano ;

Barbero, Umberto ;

Zoccai, Giuseppe Biondi ;

Moretti, Claudio ;

Ugo, Fabrizio ;

D'Amico, Maurizio ;

Garbo, Roberto ;

Stone, Gregg ;

Rettegno, Sara ;

Omede, Pierluigi ;

Conrotto, Federico ;

Templin, Christian ;

Colombo, Antonio ;

Park, Seung-Jung ;

Kastrati, Adnan ;

Hildick-Smith, David ;

Gasparini, Mauro ;

Gaita, Fiorenzo .

EUROPEAN HEART JOURNAL, 2017, 38 (42) :3160-3172

[9] Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study) [J].

D'Ascenzo, Fabrizio ;

Chieffo, Alaide ;

Cerrato, Enrico ;

Ugo, Fabrizio ;

Pavani, Marco ;

Kawamoto, Hyroishi ;

di Summa, Roberto ;

Varbella, Ferdinando ;

Boccuzzi, Giacomo ;

Omede, Pierluigi ;

Rettegno, Sara ;

Garbo, Roberto ;

Conrotto, Federico ;

Montefusco, Antonio ;

Biondi-Zoccai, Giuseppe ;

D'Amico, Maurizio ;

Moretti, Claudio ;

Escaned, Javier ;

Gaita, Fiorenzo ;

Colombo, Antonio .

AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (07) :978-982

[10] Performance of J-CTO and PROGRESS CTO Scores in Predicting Angiographic Success and Long-term Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions [J].

Forouzandeh, Farshad ;

Suh, Jon ;

Stahl, Eric ;

Ko, Yi-An ;

Lee, Suegene ;

Joshi, Udit ;

Sabharwal, Nitin ;

Almuwaqqat, Zakaria ;

Gandhi, Rounak ;

Lee, Hee Su ;

Ahn, Sung Gyun ;

Gogas, Bill D. ;

Douglas, John S. ;

Robertson, Gregory ;

Jaber, Wissam ;

Karmpaliotis, Dimitri ;

Brilakis, Emmanouil S. ;

Nicholson, William J. ;

King, Spencer B., III ;

Samady, Habib .

AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (01) :14-20

← 1 2 3 →